[Prostaglandins, kallikrein-kinin and dopamine. Practical implications of this vasodilator-natriuretic system].
D000450:Aldosterone / Q000378:metabolism; D000804:Angiotensin II / Q000378:metabolism; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001095:Arachidonic Acids / Q000494:pharmacology; D001477:Bartter Syndrome / Q000378:metabolism; D001920:Bradykinin / Q000037:antagonists & inhibitors / Q000378:metabolism; D004298:Dopamine / Q000031:analogs & derivatives / Q000378:metabolism*; D004487:Edema / Q000378:metabolism; D006801:Humans; D006929:Hyperaldosteronism / Q000378:metabolism; D006973:Hypertension / Q000378:metabolism; D007024:Hypotension, Orthostatic / Q000378:metabolism; D007610:Kallikreins / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism; D007705:Kinins / Q000378:metabolism*; D009203:Myocardial Infarction / Q000378:metabolism; D009318:Natriuresis; D011453:Prostaglandins / Q000096:biosynthesis / Q000378:metabolism*; D011954:Receptors, Dopamine / Q000187:drug effects; D012083:Renin / Q000378:metabolism; D013928:Thromboxane A2 / Q000494:pharmacology; D014664:Vasodilation
D000893:Anti-Inflammatory Agents; D001095:Arachidonic Acids; D007705:Kinins; D011453:Prostaglandins; D011954:Receptors, Dopamine; D000804:Angiotensin II; D000450:Aldosterone; D013928:Thromboxane A2; D007610:Kallikreins; D012083:Renin; D001920:Bradykinin; D004298:Dopamine
Prostaglandine,s kallicréine-kinine et dopamine. Exploitation pratique de ce système vasodilatateur-natriurétique.